Ocular Therapeutix, Inc.
OCUL · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $345 | $391 | $350 | $392 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $31 | $30 | $25 | $32 |
| Inventory | $3 | $3 | $3 | $3 |
| Other Curr. Assets | $8 | $9 | $10 | $13 |
| Total Curr. Assets | $387 | $433 | $388 | $441 |
| Property Plant & Equip (Net) | $22 | $16 | $17 | $15 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $2 | $2 | $2 | $2 |
| Total NC Assets | $24 | $18 | $18 | $17 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $411 | $451 | $406 | $458 |
| Liabilities | – | – | – | – |
| Payables | $6 | $6 | $5 | $4 |
| Short-Term Debt | $3 | $3 | $2 | $2 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $40 | $34 | $31 | $35 |
| Total Curr. Liab. | $49 | $43 | $38 | $41 |
| LT Debt | $74 | $74 | $74 | $74 |
| Deferred Rev, NC | $0 | $14 | $14 | $14 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $29 | $14 | $14 | $13 |
| Total NC Liab. | $103 | $102 | $102 | $101 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $6 | $7 | $7 | $7 |
| Total Liabilities | $153 | $145 | $140 | $143 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$1,092 | -$1,023 | -$955 | -$891 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $1,351 | $1,329 | $1,221 | $1,206 |
| Total Equity | $258 | $306 | $266 | $315 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $411 | $451 | $406 | $458 |
| Net Debt | -$268 | -$314 | -$273 | -$316 |